XHB's top holdings have shown exceptional performance and are poised for continued growth. See why I rate the fund a buy.

Invest in SPDR S&P Biotech ETF (XBI) for long-term growth potential and diverse, equal-weighted portfolio in the biotech ...

The Invesco S&P 500 CTB Net Zero Pathway ESG UCITS ETF, which is an Article 8 fund under SFDR, charges 0.09% a year.

Looking for long-term growth? Check out these top Canadian ETFs for 2025: the iShares Canadian Growth Index ETF (TSX:XCG) for ...

The DVY ETF offers market-cap-weighted exposure to U.S. companies with a consistent history of paying dividends. It has 90 ...

Buffer ETFs, also known as defined-outcome ETFs, use options contracts to limit losses while capping upside potential for the indexes they track. This type of fund has become particularly popular ...

Short-term returns shouldn’t be a measure of future success in fund investing — but tell that to the investors who put their ...

-- The January seasonal trade has begun. Here's how you can master it. Sign up here to get MarketWatch's highlights of the most timely ETF news emailed to you weekly! Subjecting the Super Bowl ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

International Business Machines (NYSE:IBM) saw a noteworthy surge on Thursday, with shares skyrocketing more than 10% ...

The Risk of “The Bigger They Come, The Harder They Fall” Retirement nest eggs vary widely in size among the public. A Pew ...

Following a strong artificial intelligence-led rally in the markets in 2024 and significant tech sector growth, investing heavily in technology or following a momentum investing approach seems ...